Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
ClinicalTrials.gov study NCT05230810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma
ClinicalTrials.gov study NCT02146118. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
ClinicalTrials.gov study NCT04511013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Residual IDH1-Mutant Tumor Cell Quantification Study
ClinicalTrials.gov study NCT07219199. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
ClinicalTrials.gov study NCT05668585. IPD Sharing: NO. Countries: 5. Publications: 0.
Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
ClinicalTrials.gov study NCT07170293. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
ClinicalTrials.gov study NCT06863506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)
ClinicalTrials.gov study NCT02342353. IPD Sharing: NO. Countries: 1. Publications: 0.
Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
ClinicalTrials.gov study NCT07001995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Aumolertinib in Patients With AI-diagnosed EGFR-mutant High-risk Pulmonary Ground-glass Opacity.
ClinicalTrials.gov study NCT05946460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
ClinicalTrials.gov study NCT06208124. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
ClinicalTrials.gov study NCT06445959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Meta
ClinicalTrials.gov study NCT07143045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma
ClinicalTrials.gov study NCT03352947. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
ClinicalTrials.gov study NCT01897116. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients
ClinicalTrials.gov study NCT05634525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lazertinib and Chemotherapy Combination in EGFR-mutant NSCLC Patients Without ctDNA Clearance After lead-in Lazertinib Monotherapy
ClinicalTrials.gov study NCT06020989. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients
ClinicalTrials.gov study NCT05528354. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT07171203. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC
ClinicalTrials.gov study NCT06934590. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.